Home :: Medication :: Relenza

Latest Relenza News

BioAlliance Pharma Appoints Former GlaxoSmithKline Executive as ... - Genetic Engineering News

Ms. Dupre, age 35, is an experienced pharmaceutical industry executive who has held positions of increasing responsibility at GlaxoSmithKline (GSK), most recently as Director of Hospital Commercial Activities, France. In this post, she Was responsible for developing the commercial Strategy for all of GSK France's hospital products as well as for negotiations with the hospitals. Prior to this position, she Was Marketing Strategy Director - HIV, Europe, responsible for GSK HIV programs, and in particular for the launch of Telzir(R) (antiprotease) throughout the EU. Earlier, she Was Product Manager, France, and launched Relenza(R), an innovative antiviral for treatment of type A and B influenza. Previously, she held product marketing positions at Bristol-Myers-Squibb in virology, where she Was in charge of two nucleoside reverse transcriptase inhibitors (NRTIs) Zerit(R) and Videx(R) for treatment of HIV, and at Bayer Pharma, where she Was involved with the launch of Glucor(R) for treatment of diabetes.

Relenza

No Ebay Marketplace Listings Found